Hypereosinophilic Syndrome Overview
Learn About Hypereosinophilic Syndrome
- Hypereosinophilic syndrome
- HES
- Hypereosinophilic syndrome, idiopathic
National Jewish Health
National Jewish Health. Dr. Wechsler is rated as an Elite provider by MediFind in the treatment of Hypereosinophilic Syndrome. His top areas of expertise are Asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Hypereosinophilic Syndrome, and Eosinophilic Asthma.
Regents Of The University Of California
Praveen Akuthota is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in San Diego, California. Dr. Akuthota is rated as an Elite provider by MediFind in the treatment of Hypereosinophilic Syndrome. His top areas of expertise are Hypereosinophilic Syndrome, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Asthma, Eosinophilic Asthma, and Gastrostomy.
Ian Pavord practices in Oxford, United Kingdom. Mr. Pavord is rated as an Elite expert by MediFind in the treatment of Hypereosinophilic Syndrome. His top areas of expertise are Eosinophilic Asthma, Asthma, Chronic Cough, and Chronic Obstructive Pulmonary Disease (COPD).
Summary: Eosinophils are a type of white blood cell. Elevated eosinophil levels can damage the heart, nerves, and other organs, in the syndrome known as hypereosinophilic syndrome (HES). Some individuals have a hereditary form of HES known as familial eosinophilia (FE). More research on the causation and mechanisms of HES is needed in order to design more effective and less toxic therapies. This study will...
Summary: The purpose of this study is to evaluate the safety and efficacy of the tyrosine kinase inhibitor, imatinib mesylate (Gleevec ) in reducing peripheral blood eosinophilia in patients with the myeloid form of hypereosinophilic syndrome (HES). Patients with the hypereosinophilic syndrome who meet a set of criteria designed to select patients with the myeloid form of the disease, as well as patients w...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


